A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis
Clinical trial NCT06588387 · COMPLETED
Trial details
- NCT number
- NCT06588387
- Sponsor
- Novartis
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-03
- Primary completion
- 2023-09-08
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.